Zobrazeno 1 - 10
of 171
pro vyhledávání: '"L, Lasser"'
Autor:
Frederik Nevens, Thierry Gustot, Pierre-François Laterre, Luc L. Lasser, Lyudmil E. Haralampiev, Victor Vargas, Desislava Lyubomirova, Agustin Albillos, Mustapha Najimi, Sébastien Michel, Ivaylo Stoykov, Noelia Gordillo, Yelena Vainilovich, Virginie Barthel, Nathalie Clerget-Chossat, Etienne M. Sokal
Publikováno v:
JHEP Reports, Vol 3, Iss 4, Pp 100291- (2021)
Background & Aims: Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorat
Externí odkaz:
https://doaj.org/article/87165a53850a4e95821f7ce0ed7fdee3
Autor:
C. Van Steenkiste, Mike Cool, L Lasser, V. Lefèbvre, Thomas Vanwolleghem, Xavier Verhelst, K Venken, Suzanne Bourgeois, Stephanie Coulon, Isabelle Colle, J P Mulkay, J Decaestecker, G. Robaeys
Publikováno v:
Acta gastro-enterologica belgica
Objective : To describe comorbidities and concomitant medications in patients initiating treatment for hepatitis C virus (HCV) infection with direct-acting antiviral (DAA) regimens in Belgium. Methods : This was a noninterventional, observational, mu
Autor:
Sébastien Michel, Mustapha Najimi, Yelena Vainilovich, Virginie Barthel, Luc L. Lasser, Victor Vargas, Desislava Lyubomirova, Agustín Albillos, Etienne Sokal, Noelia Gordillo, Nathalie Clerget-Chossat, Frederik Nevens, Pierre-François Laterre, Lyudmil E. Haralampiev, Thierry Gustot, Ivaylo Stoykov
Publikováno v:
JHEP Reports
JHEP Reports, 3 (4
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
JHEP Reports, Vol 3, Iss 4, Pp 100291-(2021)
JHEP Reports, Vol. 3, no. 4, p. 100291 [1-10] (2021)
JHEP Reports, 3 (4
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
JHEP Reports, Vol 3, Iss 4, Pp 100291-(2021)
JHEP Reports, Vol. 3, no. 4, p. 100291 [1-10] (2021)
Background & Aims: Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21f831201daccbe657298e10bc15d2
https://lirias.kuleuven.be/handle/123456789/677657
https://lirias.kuleuven.be/handle/123456789/677657
Autor:
G, Muyldermans, R, Bielen, R, Botterman, S, Bourgeois, I, Colle, B, Deressa, G, Devolder, Y, Horsmans, V, Hutse, N, Lanthier, L, Lasser, S, Platteau, G, Robaeys, V, Suin, X, Verhelst, H, Van Vlierberghe, L, Van Baelen
Publikováno v:
Acta gastro-enterologica Belgica. 82(4)
Although multiple HCV prevalence studies were recently performed in the general population from Belgium, they suffer from a lack of geographical representativeness, an insufficient number of participants or a lack of inclusion of high prevalence grou
Autor:
S, Bourgeois, J P, Mulkay, L, Lasser, G, Robaeys, B, Bastens, J, Delwaide, S, Pollet, M, Van den Enden
Publikováno v:
Acta gastro-enterologica Belgica. 82(1)
Direct-acting antivirals provide interferon-free treatments for chronic hepatitis C (CHC) virus infection. In Belgium, in 2016, access to these agents was limited to patients with advanced liver fibrosis stages F3 and F4. This study is the first to d
Autor:
L Lasser, Hans Van Vlierberghe, G. Robaeys, I. Colle, Philippe Langlet, Michael Adler, Okyay Elkilic, An Reekmans, Chantal de Galocsy, Jean-Pierre Mulkay, Nathalie Boon
Publikováno v:
Global Journal of Clinical Virology. 1:001-004
Persistently normal alanine aminotransferase (PNALT) is present in 30 to 40% of chronic hepatitis patients and it is generally accepted that they have no liver damage. However, some studies suggest that there are some degrees of mild to moderate hist
Autor:
L Lasser, J Decaestecker, Thomas Vanwolleghem, Jean-Pierre Mulkay, Geert Robaeys, V. Xavier, Katrien Venken, V. Lefèbvre, Isabelle Colle, Suzanne Bourgeois, Stephanie Coulon, Mike Cool, Christophe Van Steenkiste
Publikováno v:
Journal of Hepatology. 70:e491-e492
Autor:
Alan M. Robson, Joanne F. Dorgan, Victor J. Stevens, Catherine Klifa, Peter O. Kwiterovich, Linda Van Horn, John A. Shepherd, Brian L. Egleston, Norman L. Lasser, Linda Snetselaar, Nola M. Hylton, Snehal Deshmukh
Publikováno v:
Cancer causes & control : CCC, vol 24, iss 11
PurposeBreast density is strongly related to breast cancer risk, but determinants of breast density in young women remain largely unknown.MethodsAssociations of reproductive and menstrual characteristics with breast density measured by magnetic reson
Autor:
Antoine Hadengue, Jonel Trebicka, Aurélie Plessier, Harry L.A. Janssen, Sarwa Darwish Murad, L Lasser, Juan G. Abraldes, Kinan Rifai, Jildou Hoekstra, Elwyn Elias, Massimo Primignani, Isabelle Morard, Susana Seijo, Jörg Heller, Dalvinder Mandair, Juan Carlos García-Pagán, Dominique Valla, Alessandra Dell'Era
Publikováno v:
Hepatology, 57(5), 1962-1968. John Wiley & Sons Ltd.
Budd-Chiari syndrome (BCS) is a rare, life-threatening disease caused by obstruction of hepatic venous outflow. The aim of the study was to assess long-term outcome and identify prognostic factors in BCS patients managed by a step-wise approach using
Autor:
Peter Michielsen, Christophe Moreno, Marie de Vos, Pierre Deltenre, Chantal de Galocsy, Astrid Marot, Jean Delwaide, Isabelle Colle, Hans Van Vlierberghe, Marc Van Gossum, L Lasser, Jean Henrion, Wim Laleman, Thomas Sersté, Hans Orlent, Jean-François Knebel, Christophe George, Sven Francque, Eric Trepo, Hélène Vandenbulcke, Christopher Doerig
Publikováno v:
Journal of hepatology
Journal of hepatology, Vol. 65, no. 3, p. 543-51 (2016)
Journal of hepatology, Vol. 65, no. 3, p. 543-51 (2016)
Background & Aims: Whether alcohol intake increases the risk of complications in patients with HCV-related cirrhosis remains unclear. The aim of this study was to determine the impact of alcohol intake and viral eradication on the risk of hepatocellu